Literature DB >> 15276620

Phospholipase C-delta1 rescues intracellular Ca2+ overload in ischemic heart and hypoxic neonatal cardiomyocytes.

Ki-Chul Hwang1, Soyeon Lim, Hyuck Moon Kwon, Yun Soo Bae, Seok-Min Kang, Kwang-Hoe Chung, Robert M Graham, Sue Goo Rhee, Yangsoo Jang.   

Abstract

Ischemia and simulated ischemic conditions cause intracellular Ca2+ overload in the myocardium. The relationship between ischemia injury and Ca2+ overload has not been fully characterized. The aim of the present study was to investigate the expression and characteristics of PLC isozymes in myocardial infarction-induced cardiac remodeling and heart failure. In normal rat heart tissue, PLC-delta1 (about 44 ng/mg of heart tissue) was most abundant isozymes compared to PLC-gamma1 (6.8 ng/mg) and PLC-beta1 (0.4 ng/mg). In ischemic heart and hypoxic neonatal cardiomyocytes, PLC-delta1, but not PLC-beta1 and PLC-gamma1, was selectively degraded, a response that could be inhibited by the calpain inhibitor, calpastatin, and by the caspase inhibitor, zVAD-fmk. Overexpression of the PLC-delta1 in hypoxic neonatal cardiomyocytes rescued intracellular Ca2+ overload by ischemic conditions. In the border zone and scar region of infarcted myocardium, and in hypoxic neonatal cardiomyocytes, the selective degradation of PLC-delta1 by the calcium sensitive proteases may play important roles in intracellular Ca2+ regulations under the ischemic conditions. It is suggested that PLC isozyme-changes may contribute to the alterations in calcium homeostasis in myocardial ischemia. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276620     DOI: 10.1016/j.jsbmb.2004.02.009

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  4 in total

1.  PLCδ1 protein rescues ischemia-reperfused heart by the regulation of calcium homeostasis.

Authors:  Soyeon Lim; Woochul Chang; Min-Ji Cha; Byeong-Wook Song; Onju Ham; Se-Yeon Lee; Changyoun Lee; Jun-Hee Park; Sang-Kyou Lee; Yangsoo Jang; Ki-Chul Hwang
Journal:  Mol Ther       Date:  2014-03-18       Impact factor: 11.454

2.  Neuropeptide Y reduces the expression of PLCB2, PLCD1 and selected PLC genes in cultured human endothelial cells.

Authors:  V R Lo Vasco; M Leopizzi; C Puggioni; C Della Rocca; R Businaro
Journal:  Mol Cell Biochem       Date:  2014-06-06       Impact factor: 3.396

3.  Glycine inhibits the LPS-induced increase in cytosolic Ca2+ concentration and TNFalpha production in cardiomyocytes by activating a glycine receptor.

Authors:  Hua-dong Wang; Xiu-xiu Lü; Da-xiang Lu; Ren-bin Qi; Yan-ping Wang; Yong-mei Fu; Li-wei Wang
Journal:  Acta Pharmacol Sin       Date:  2009-07-20       Impact factor: 6.150

Review 4.  Gap junction modulation and its implications for heart function.

Authors:  Stefan Kurtenbach; Sarah Kurtenbach; Georg Zoidl
Journal:  Front Physiol       Date:  2014-02-27       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.